G7 on antibiotic resistance
October 20, 2015
Modern healthcare
use of antimicrobial
therapies (AMTs) is
endangering their
effectiveness by increasing
the spread of resistant
microbes according to a
report from the recent G7
Health Ministers Meeting
held in Berlin, Germany.
Antimicrobial resistance
is rapidly becoming a top
health problem that could
pose a significant challenge to the
functioning of healthcare systems
and their budget.
Antibiotic resistant microbes
(ARMs) are highly prevalent in
G7 and OECD countries, said the
report.
Patients infected by ARMs
are more likely to develop
complications and up to three
times more likely to die creating an
additional cost burden for hospital
spend, on average, of US$10,000 to
40,000 for each patient involved.
The chart demonstrates penicillin
resistant pneumonia graphed
against total antibiotic use by
country, with Australia looking
relatively less implicated in the
problem.
The findings have spurred a
call for more urgent action by G7
countries in the area of AMR.
All G7 countries have developed
policies to tackle AMR in both the
human and animal sectors.
The above article was sent to subscribers in Pharmacy Daily's issue from 20 Oct 15To see the full newsletter, see the embedded issue below or CLICK HERE to download Pharmacy Daily from 20 Oct 15
